elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47193084-E0ACF49D-82D8-4C88-A53C-0FC20B8B77DC
Q47193084-E0ACF49D-82D8-4C88-A53C-0FC20B8B77DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47193084-E0ACF49D-82D8-4C88-A53C-0FC20B8B77DC
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.
P2860
Q47193084-E0ACF49D-82D8-4C88-A53C-0FC20B8B77DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47193084-E0ACF49D-82D8-4C88-A53C-0FC20B8B77DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c25a56807d036286c4de66bdcc3d0150140fa70
P2860
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.